Group-based Pulmonary Telerehabilitation is Feasible, Safe, Beneficial and Well-received in Patients Who Have Been Hospitalised with COVID-19

Overview

Journal ERJ Open Res

Specialty Pulmonary Medicine

Date 2023 Mar 14

PMID 36915803

Authors

Andrew J Simpson

Angela Green

Marion Nettleton

Lucy Hyde

Joanne Shepherdson

Clare Killingback

Phil Marshall

Michael G Crooks

Affiliations

Soon will be listed here.

Abstract

Introduction: Coronavirus disease 2019 (COVID-19) has caused worldwide mass hospitalisation. The need for multidisciplinary post-hospitalisation rehabilitation is becoming increasingly apparent, and telerehabilitation has been endorsed. The aim of study was to investigate the feasibility and efficacy of pulmonary telerehabilitation for COVID-19 survivors.

Methods: This was a single-centre, mixed-methods, fast-track (wait-list), randomised controlled trial of telerehabilitation for patients who had been hospitalised with COVID-19. 40 patients discharged from two university teaching hospitals in the north of England were recruited. Telerehabilitation consisted of 12 exercise classes, six education events and opportunity for peer support. Patients commenced telerehabilitation 14 days after randomisation in the fast-track group and 56 days after randomisation in the wait-list group.

Outcome Measures And Results: Descriptive and statistical improvements were noted in several clinical outcome measures. Exercise capacity increased from a median (interquartile range) 20 (14-24) sit-to-stand repetitions in 1 min at baseline to 25 (24-30) post-telerehabilitation. Breathlessness rated using the Medical Research Council dyspnoea scale changed from 3.5 (3-4) at baseline to 2 (1.5-3) post-telerehabilitation, with additional favourable outcomes noted in respiratory symptoms measured using numerical rating scales and visual analogue scales (VAS). Quality of life measured using the EuroQol VAS improved from 55 (60-70) units at baseline to 70 (55-80) units following telerehabilitation. Improvements in fatigue (modified Functional Assessment of Chronic Illness Therapy: Fatigue) and mood (Hospital Anxiety and Depression Scale - Depression) were also observed. Natural recovery was observed in the wait-list group prior to receiving telerehabilitation; however, improvements were accelerated by early telerehabilitation in the fast-track group.

Conclusions: We have shown that group-based telerehabilitation is feasible, safe, beneficial and well-received in this population.

Citing Articles

Adverse events associated with the delivery of telerehabilitation across rehabilitation populations: A scoping review.

Yau T, Chan J, McIntyre M, Bhogal D, Andreoli A, Leochico C PLoS One. 2024; 19(11):e0313440.

PMID: 39561143 PMC: 11575805. DOI: 10.1371/journal.pone.0313440.

References

Wade D . What is rehabilitation? An empirical investigation leading to an evidence-based description. Clin Rehabil. 2020; 34(5):571-583. PMC: 7350200. DOI: 10.1177/0269215520905112. View

Al-Shair K, Muellerova H, Yorke J, Rennard S, Wouters E, Hanania N . Examining fatigue in COPD: development, validity and reliability of a modified version of FACIT-F scale. Health Qual Life Outcomes. 2012; 10:100. PMC: 3491053. DOI: 10.1186/1477-7525-10-100. View

Thorpe O, Johnston K, Kumar S . Barriers and enablers to physical activity participation in patients with COPD: a systematic review. J Cardiopulm Rehabil Prev. 2012; 32(6):359-69. DOI: 10.1097/HCR.0b013e318262d7df. View

Bestall J, Paul E, Garrod R, Garnham R, Jones P, Wedzicha J . Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999; 54(7):581-6. PMC: 1745516. DOI: 10.1136/thx.54.7.581. View

Salawu A, Green A, Crooks M, Brixey N, Ross D, Sivan M . A Proposal for Multidisciplinary Tele-Rehabilitation in the Assessment and Rehabilitation of COVID-19 Survivors. Int J Environ Res Public Health. 2020; 17(13). PMC: 7369849. DOI: 10.3390/ijerph17134890. View

Blandford A, Wesson J, Amalberti R, AlHazme R, Allwihan R . Opportunities and challenges for telehealth within, and beyond, a pandemic. Lancet Glob Health. 2020; 8(11):e1364-e1365. PMC: 7417162. DOI: 10.1016/S2214-109X(20)30362-4. View

Zigmond A, SNAITH R . The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67(6):361-70. DOI: 10.1111/j.1600-0447.1983.tb09716.x. View

Crook S, Busching G, Schultz K, Lehbert N, Jelusic D, Keusch S . A multicentre validation of the 1-min sit-to-stand test in patients with COPD. Eur Respir J. 2017; 49(3). DOI: 10.1183/13993003.01871-2016. View

Carfi A, Bernabei R, Landi F . Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020; 324(6):603-605. PMC: 7349096. DOI: 10.1001/jama.2020.12603. View

10.

Gloeckl R, Leitl D, Jarosch I, Schneeberger T, Nell C, Stenzel N . Benefits of pulmonary rehabilitation in COVID-19: a prospective observational cohort study. ERJ Open Res. 2021; 7(2). PMC: 7957293. DOI: 10.1183/23120541.00108-2021. View

11.

Strassmann A, Steurer-Stey C, Dalla Lana K, Zoller M, Turk A, Suter P . Population-based reference values for the 1-min sit-to-stand test. Int J Public Health. 2013; 58(6):949-53. DOI: 10.1007/s00038-013-0504-z. View

12.

Wysham N, Miriovsky B, Currow D, Herndon 2nd J, Samsa G, Wilcock A . Practical Dyspnea Assessment: Relationship Between the 0-10 Numerical Rating Scale and the Four-Level Categorical Verbal Descriptor Scale of Dyspnea Intensity. J Pain Symptom Manage. 2015; 50(4):480-7. PMC: 5008963. DOI: 10.1016/j.jpainsymman.2015.04.015. View

13.

Busching G, Zhang Z, Schmid J, Sigrist T, Khatami R . Effectiveness of Pulmonary Rehabilitation in Severe and Critically Ill COVID-19 Patients: A Controlled Study. Int J Environ Res Public Health. 2021; 18(17). PMC: 8430691. DOI: 10.3390/ijerph18178956. View

14.

Li J, Xia W, Zhan C, Liu S, Yin Z, Wang J . A telerehabilitation programme in post-discharge COVID-19 patients (TERECO): a randomised controlled trial. Thorax. 2021; 77(7):697-706. PMC: 8318721. DOI: 10.1136/thoraxjnl-2021-217382. View

15.

Heightman M, Prashar J, Hillman T, Marks M, Livingston R, Ridsdale H . Post-COVID-19 assessment in a specialist clinical service: a 12-month, single-centre, prospective study in 1325 individuals. BMJ Open Respir Res. 2021; 8(1). PMC: 8587466. DOI: 10.1136/bmjresp-2021-001041. View

16.

Hermann M, Pekacka-Egli A, Witassek F, Baumgaertner R, Schoendorf S, Spielmanns M . Feasibility and Efficacy of Cardiopulmonary Rehabilitation After COVID-19. Am J Phys Med Rehabil. 2020; 99(10):865-869. PMC: 7406212. DOI: 10.1097/PHM.0000000000001549. View

17.

Sykes D, Holdsworth L, Jawad N, Gunasekera P, Morice A, Crooks M . Post-COVID-19 Symptom Burden: What is Long-COVID and How Should We Manage It?. Lung. 2021; 199(2):113-119. PMC: 7875681. DOI: 10.1007/s00408-021-00423-z. View

18.

Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D . Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011; 20(10):1727-36. PMC: 3220807. DOI: 10.1007/s11136-011-9903-x. View

19.

Lacasse Y, Guyatt G, Goldstein R . The components of a respiratory rehabilitation program: a systematic overview. Chest. 1997; 111(4):1077-88. DOI: 10.1378/chest.111.4.1077. View

20.

Zanini A, Aiello M, Adamo D, Casale S, Cherubino F, Della Patrona S . Estimation of minimal clinically important difference in EQ-5D visual analog scale score after pulmonary rehabilitation in subjects with COPD. Respir Care. 2014; 60(1):88-95. DOI: 10.4187/respcare.03272. View